Germany:Saltigo to showcase its impressive portfolio at Chemspec

Saltigo GmbH, a global service provider for custom synthesis and custom manufacturing, will showcase its impressive portfolio at Chemspec Europe 2008, which takes place in Munich on June 18 and 19.
This wholly owned subsidiary of specialty chemicals group LANXESS AG offers tailor-made solutions for customers from the crop protection and pharmaceutical sector as well as for various non-life science industries.
“Our customers particularly value our ability to support them throughout the entire product lifecycle – from process development through piloting to commercial production,” explains Dr. Uwe Brunk, head of the Agro & Specialty Chemicals (A&SC) business line.
“Our expertise in process optimization is one of the most important success factors, enabling us to develop our business successfully in the face of international competition.
This depends in particular on having cost-optimized, robust processes and reliable technical transferability.
Our expertise repeatedly enables us to break new ground using syntheses that are often more streamlined than classical routes, allowing costs to be cut and giving our customers an edge on their markets,” explains Volker Jesse, head of marketing for A&SC.
Saltigo’s service portfolio comprises the development and optimization of chemical syntheses, the piloting and upscaling of existing processes and the large-scale production of complex molecules.
This subsidiary also provides its customers with skilled support on issues related to analytics, supply chain optimization and the registration of substances.

A worldwide network of experienced experts offers comprehensive expertise in managing sophisticated reaction steps and sequences, e.g. asymmetrical, catalytic hydrogenation, reactions at low temperatures (down to -100 °C) or under high pressure. Compounds with azides, hydrocyanic acid, fluorine and phosgene are also handled reliably and safely.
With a comprehensive reaction and technology portfolio, projects can either be based on existing technical packages or on newly developed, customized synthesis routes.
This set up means that a whole range of substances can be delivered reliably and cost-effectively on virtually any scale -from just a few kilograms to several hundred tons.
The insect repellant Saltidin is an exception in Saltigo’s portfolio and underlines the company’s ability to build on its resources to develop a product-based business.
Saltidin is the new trade name for the proven active ingredient Icaridin, which was previously marketed as Bayrepel. “The new Saltidin name is more clearly related to Saltigo,” says Diana Rudolph, who has global responsibility for Saltidin business.
“Many users find its ease of application convenient”, she adds. For example, many formulations containing Saltidin do not leave a sticky film on the skin once they have been rubbed in.
“Moreover, our product does not smell unpleasant, nor does it damage plastics as badly as other products,” explains Rudolph.
This state-of-the-art insect repellent, which is recommended by the World Health Organization (WHO), has been helping to combat deadly diseases such as malaria and yellow fever since it was first launched on the market in 1998.